Shares of Aurora Cannabis Inc. (TSE:ACB - Get Free Report) crossed above its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of C$5.65 and traded as high as C$5.85. Aurora Cannabis shares last traded at C$5.81, with a volume of 215,864 shares.
Analyst Ratings Changes
Several analysts have recently commented on the company. ATB Cormark Capital Markets increased their price objective on Aurora Cannabis from C$5.60 to C$7.00 and gave the company a "tender" rating in a report on Tuesday, October 6th. Canaccord Genuity Group dropped their target price on Aurora Cannabis from C$6.50 to C$5.00 and set a "buy" rating on the stock in a research note on Tuesday, June 30th. Finally, BMO Capital Markets raised Aurora Cannabis to a "hold" rating in a research report on Wednesday, August 5th. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of C$6.67.
Check Out Our Latest Research Report on ACB
Aurora Cannabis Stock Up 5.8%
The stock has a market capitalization of C$359.97 million, a PE ratio of -2.99 and a beta of 0.64. The company has a current ratio of 5.36, a quick ratio of 2.48 and a debt-to-equity ratio of 4.30. The company's 50-day moving average is C$5.65 and its 200 day moving average is C$4.94.
Aurora Cannabis (TSE:ACB - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported C($0.07) earnings per share for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%. The company had revenue of C$67.55 million for the quarter. As a group, analysts anticipate that Aurora Cannabis Inc. will post -0.22 EPS for the current year.
Aurora Cannabis Company Profile
(
Get Free Report)
Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty's ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.
